All

Blog

News

Case Studies

Video

Search Article…

Case Study

Re-engineering FMC63 for CD19 CAR-T: Humanization, De-immunization, and Improved Developability in a Single Pass

Case Study

One Model, Four Targets: Zero-Shot, Generalizable Affinity Maturation with ConvergeAB™

Case Study

Multiple Myeloma: tissue, staging, and target discovery, zero-shot with ConvergeCELL™

Case Study

Zero-Shot Design of a Biobetter Cetuximab: Enhancing EGFR Binding with ConvergeAB™

Case Study

Generating Clinic-Ready Antibodies: Benchmarking ConvergeAB™ Against Blockbuster Drugs

Case Study

ConvergeGEO™ vs. The Industry: Converge Bio Leads the Field in Zero-Shot Therapeutic Protein Yield Optimization

Case Study

Indication-agnostic biomarker and target discovery across complex disease systems

Case Study

3D ribbon-like protein structure with yellow segments marking editable regions and grey segments marking non-editable regions. Text on the left reads ‘Intellectual Property Expansion’ with a small color legend for editable and non-editable areas

AI-driven IP expansion: scientific and operational breakthroughs using innovative antibody design

Case Study

Achieving a 4.5x Increase in Protein Yield with ConvergeGEO